These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1757105)
1. The role of rIL-2 in the modulation of cellular immunity in resistance to infection. Kaplan G Immunol Lett; 1991 Oct; 30(2):199-200. PubMed ID: 1757105 [No Abstract] [Full Text] [Related]
2. The role of rIL-2 in the modulation of cellular immunity in resistance to infection. Kaplan G Behring Inst Mitt; 1991 Feb; (88):228-9. PubMed ID: 2049043 [No Abstract] [Full Text] [Related]
3. Immunoreactivity of T-cells from leprosy patients to ICRC and M. leprae antigens before and after vaccination. Gangal SG; Chiplunkar SV; Shinde SR; Samson PD; Deo MG Trop Med Parasitol; 1990 Sep; 41(3):314-6. PubMed ID: 1701562 [No Abstract] [Full Text] [Related]
4. Cellular and humoral immune responses to recombinant 65-kD antigen of Mycobacterium leprae in leprosy patients and healthy controls. Ilangumaran S; Shanker Narayan NP; Ramu G; Muthukkaruppan VR Clin Exp Immunol; 1994 Apr; 96(1):79-85. PubMed ID: 8149671 [TBL] [Abstract][Full Text] [Related]
5. A comparative study on the effects of rIL-4, rIL-2, rIFN-gamma, and rTNF-alpha on specific T-cell non-responsiveness to mycobacterial antigens in lepromatous leprosy patients in vitro. Ottenhoff TH; Wondimu A; Reddy NN Scand J Immunol; 1990 May; 31(5):553-65. PubMed ID: 2111939 [TBL] [Abstract][Full Text] [Related]
6. Alteration of T cell subset pattern among in vitro M. leprae-stimulated blood lymphocytes of leprosy patients. Corbeau P; Desforges S; Bach MA Acta Leprol; 1989; 7 Suppl 1():171-2. PubMed ID: 2569800 [No Abstract] [Full Text] [Related]
7. The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2. Kaplan G; Kiessling R; Teklemariam S; Hancock G; Sheftel G; Job CK; Converse P; Ottenhoff TH; Becx-Bleumink M; Dietz M J Exp Med; 1989 Mar; 169(3):893-907. PubMed ID: 2494293 [TBL] [Abstract][Full Text] [Related]
8. Human immune response to recombinant interferon gamma and protein antigen LSR2. Nath I; Laal S; Sivasai KS; Tangri S; Murtaza A; Singh S; Wilfred D; Misra RS Trop Med Parasitol; 1990 Sep; 41(3):324-5. PubMed ID: 1701565 [No Abstract] [Full Text] [Related]
9. Mechanisms of Mycobacterium leprae-specific T-cell deficiency in lepromatous leprosy. Bach MA; Launois P Biochimie; 1988 Aug; 70(8):1013-8. PubMed ID: 3147697 [TBL] [Abstract][Full Text] [Related]
10. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls. Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589 [TBL] [Abstract][Full Text] [Related]
11. Intradermal recombinant interleukin 2 enhances peripheral blood T-cell responses to mitogen and antigens in patients with lepromatous leprosy. Converse P; Ottenhoff TH; Work Teklemariam S; Hancock GE; Dietz M; Becx-Bleumink M; Wondimu A; Kiessling R; Cohn ZA; Kaplan G Scand J Immunol; 1990 Aug; 32(2):83-91. PubMed ID: 2389115 [TBL] [Abstract][Full Text] [Related]
12. The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy. Kaplan G; Britton WJ; Hancock GE; Theuvenet WJ; Smith KA; Job CK; Roche PW; Molloy A; Burkhardt R; Barker J J Exp Med; 1991 Apr; 173(4):993-1006. PubMed ID: 2007862 [TBL] [Abstract][Full Text] [Related]
13. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients. Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851 [TBL] [Abstract][Full Text] [Related]
14. A role for IL-12 receptor expression and signal transduction in host defense in leprosy. Kim J; Uyemura K; Van Dyke MK; Legaspi AJ; Rea TH; Shuai K; Modlin RL J Immunol; 2001 Jul; 167(2):779-86. PubMed ID: 11441083 [TBL] [Abstract][Full Text] [Related]
15. AP-1 is present in nuclear extracts of lymphocytes from lepromatous leprosy patients. Huizar-López R; Santerre A; Madrid-Marina V; Peralta-Zaragoza O; Villalobos-Arámbula A; Islas-Rodríguez A Int J Lepr Other Mycobact Dis; 2002 Dec; 70(4):274-7. PubMed ID: 12768929 [No Abstract] [Full Text] [Related]
17. Immunology of a burnt-out lepromatous leprosy patient. Baliña LN; Jotimliansky L; Sasiain MC; Minnucci F; Kien MC; Chouela E Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):102-4. PubMed ID: 1602187 [No Abstract] [Full Text] [Related]
18. IL-2 and IL-12 act in synergy to overcome antigen-specific T cell unresponsiveness in mycobacterial disease. de Jong R; Janson AA; Faber WR; Naafs B; Ottenhoff TH J Immunol; 1997 Jul; 159(2):786-93. PubMed ID: 9218596 [TBL] [Abstract][Full Text] [Related]
19. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines. Mustafa AS Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259 [TBL] [Abstract][Full Text] [Related]
20. Genetic control of immunopathology induced by Mycobacterium leprae. de Vries RR Am J Trop Med Hyg; 1991 Apr; 44(4 Pt 2):12-6. PubMed ID: 1904200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]